SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-162366
Filing Date
2022-05-27
Accepted
2022-05-27 16:17:19
Documents
15
Period of Report
2022-05-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d360274d8k.htm   iXBRL 8-K 48953
2 EX-3.1 d360274dex31.htm EX-3.1 242269
3 EX-3.2 d360274dex32.htm EX-3.2 224626
7 GRAPHIC g360274j05k05.jpg GRAPHIC 3751
  Complete submission text file 0001193125-22-162366.txt   726211

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA atai-20220525.xsd EX-101.SCH 2837
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE atai-20220525_lab.xml EX-101.LAB 19416
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atai-20220525_pre.xml EX-101.PRE 12117
9 EXTRACTED XBRL INSTANCE DOCUMENT d360274d8k_htm.xml XML 3787
Mailing Address 180 VARICK STREET NEW YORK NY 10014
Business Address 180 VARICK STREET NEW YORK NY 10014 (617) 699-5876
ATAI Life Sciences N.V. (Filer) CIK: 0001840904 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40493 | Film No.: 22977751
SIC: 2834 Pharmaceutical Preparations